FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Info Collection on Good Lab Practices

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Good Laboratory Practice Requirements ...

Info Collection on IND Requirements

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Investigational New Drug Application Require...

Device Tracking Info Collection

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension entitled Medical Devices; Device Tracking 21 C...

FDA Warns Overseas OTC Manufacturers

[ Price : $8.95]

FDA warns six overseas manufacturers of over-the-counter drugs about CGMP violations.

CBER Allowing Device In-Person Meetings

[ Price : $8.95]

CBER begins a phased implementation of in-person industry meetings with device manufacturers.

BIO Supports FDAs AI/ML Discussion

[ Price : $8.95]

The Biotechnology Innovation Organization says it supports FDA efforts to promote stakeholder discussion on the role of artificial...

Wegovy Hits Trial MACE Goal

[ Price : $8.95]

Novo Nordisk says its Wegovy cut the risk of major adverse cardiovascular events by 20% in overweight or obese adults in the SELEC...

FDA OKs Boston Scientific Cryoablation Device

[ Price : $8.95]

FDA approves a Boston Scientific PMA for the POLARx Cryoablation System for treating patients with paroxysmal atrial fibrillation.

QTc Labeling Information Guidance

[ Price : $8.95]

FDA publishes a draft guidance on incorporating QTc prolongation-related information in drug and biological product labeling.

Cubicin Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that Cubist Pharmaceuticals Cubicin and Cubicin RF (daptomycin) powder for injection were ...